Philippe Seksik
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.
Journal: Journal of Crohn's & colitis
Published: July 22, 2026
Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation by Sutterella species.
Journal: Gut microbes
Published: June 22, 2026
Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 08, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.
Journal: Alimentary pharmacology & therapeutics
Published: February 17, 2026
Anti-TNF Drug-Induced Sarcoidosis in Inflammatory Bowel Diseases: Multicentric Case Series and Literature Review.
Journal: BioMed research international
Published: February 12, 2026
Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 24, 2026
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: November 30, 2025
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 07, 2025
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 04, 2025
Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.
Journal: Journal of Crohn's & colitis
Published: September 08, 2025
Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UC.
Journal: Clinics and research in hepatology and gastroenterology
Published: June 08, 2025
Impact of Endometriosis on the Progression of Inflammatory Bowel Diseases: A Multicenter Retrospective Study.
Journal: Clinical and translational gastroenterology
Published: May 14, 2025
Last Updated: 09/26/2026